Free Trial

ADC Therapeutics (ADCT) Insider Trading & Ownership

ADC Therapeutics logo
$3.86 +0.10 (+2.53%)
Closing price 03:59 PM Eastern
Extended Trading
$3.84 -0.02 (-0.52%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADC Therapeutics (NYSE:ADCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$19.64M
Get ADCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling ADC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ADCT Insider Buying and Selling by Quarter

ADC Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2026
Redmile Group, Llc
Major Shareholder
Sell2,529,491$3.28$8,296,730.48  
4/2/2026
Redmile Group, Llc
Major Shareholder
Sell2,634,506$3.28$8,641,179.68  
4/1/2026
Redmile Group, Llc
Major Shareholder
Sell162,517$3.80$617,564.60  
4/1/2026
Redmile Group, Llc
Major Shareholder
Sell169,265$3.80$643,207.00  
3/31/2026
Redmile Group, Llc
Major Shareholder
Sell188,407$3.75$706,526.25  
3/31/2026
Redmile Group, Llc
Major Shareholder
Sell196,229$3.75$735,858.75  
(Data available from 1/1/2013 forward)

ADCT Insider Trading Activity - Frequently Asked Questions

The list of insiders at ADC Therapeutics includes Ameet Mallik, Redmile Group, Llc, and Robert Azelby. Learn more on insiders at ADCT.

5.40% of ADC Therapeutics stock is owned by insiders. Learn more on ADCT's insider holdings.

The following insider purchased ADCT shares in the last 24 months: Redmile Group, Llc ($1,428,000.00).

Insiders have purchased a total of 500,000 ADCT shares in the last 24 months for a total of $1,428,000.00 bought.

The following insiders have sold ADCT shares in the last 24 months: Ameet Mallik ($133,194.88), Redmile Group, Llc ($19,693,545.40), and Robert Azelby ($20,215.55).

Insiders have sold a total of 5,942,493 ADC Therapeutics shares in the last 24 months for a total of $19,846,955.83 sold.

ADC Therapeutics Active Insiders



This page (NYSE:ADCT) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners